RETRACTED ARTICLE: Tridax procumbens flavonoids promote osteoblast differentiation and bone formation
0301 basic medicine
Core Binding Factor Alpha 1 Subunit
Asteraceae
Osteogenesis
Orthopedics and Sports Medicine
Biology (General)
Medicine(all)
Osteoblast differentiation
Agricultural and Biological Sciences(all)
Reverse Transcriptase Polymerase Chain Reaction
Osteoblast
Life Sciences
Cell Differentiation
Osteoblast Differentiation
Up-Regulation
3. Good health
Sp7 Transcription Factor
Bone formation
Bone Morphogenetic Proteins
Osteoclast Differentiation
Medicine
Research Article
QH301-705.5
Osteocalcin
Primary Cell Culture
03 medical and health sciences
Calcification, Physiologic
In vitro
Biochemistry, Genetics and Molecular Biology
Alkaline phosphatase
Health Sciences
Genetics
Animals
Molecular Biology
Biology
Flavonoids
Pharmacology
Osteoblasts
Biochemistry, Genetics and Molecular Biology(all)
Skull
Botany
Traditional medicine
Alkaline Phosphatase
Mice, Inbred C57BL
Molecular Mechanisms of Osteoclast Differentiation and Bone Remodeling
Therapeutic Potential of Boswellic Acids and Related Compounds
FOS: Biological sciences
Osteoporosis
Medicine, Traditional
Transcription Factors
DOI:
10.1186/s40659-015-0056-1
Publication Date:
2015-11-18T12:56:40Z
AUTHORS (6)
ABSTRACT
Abstract
Background
Tridax procumbens flavonoids (TPFs) are well known for their medicinal properties among local natives. Besides traditionally used for dropsy, anemia, arthritis, gout, asthma, ulcer, piles, and urinary problems, it is also used in treating gastric problems, body pain, and rheumatic pains of joints. TPFs have been reported to increase osteogenic functioning in mesenchymal stem cells. Our previous study showed that TPFs were significantly suppressed the RANKL-induced differentiation of osteoclasts and bone resorption. However, the effects of TPFs to promote osteoblasts differentiation and bone formation remain unclear. TPFs were isolated from Tridax procumbens and investigated for their effects on osteoblasts differentiation and bone formation by using primary mouse calvarial osteoblasts.
Results
TPFs promoted osteoblast differentiation in a dose-dependent manner demonstrated by up-regulation of alkaline phosphatase and osteocalcin. TPFs also upregulated osteoblast differentiation related genes, including osteocalcin, osterix, and Runx2 in primary osteoblasts. TPFs treated primary osteoblast cells showed significant upregulation of bone morphogenetic proteins (BMPs) including Bmp-2, Bmp-4, and Bmp-7. Addition of noggin, a BMP specific-antagonist, inhibited TPFs induced upregulation of the osteocalcin, osterix, and Runx2.
Conclusion
Our findings point towards the induction of osteoblast differentiation by TPFs and suggested that TPFs could be a potential anabolic agent to treat patients with bone loss-associated diseases such as osteoporosis.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (53)
CITATIONS (9)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....